Document is current
Any future updates will be listed below
-
Authors
Boguszewski, Cesar L. https://orcid.org/0000-0001-7285-7941
Korbonits, Márta https://orcid.org/0000-0002-4101-9432
Artignan, Audrey https://orcid.org/0000-0002-0354-1158
García, Almudena Martín
Houchard, Aude https://orcid.org/0000-0001-6248-8986
Ribeiro-Oliveira, Antonio Jr https://orcid.org/0000-0002-6114-5786
de Herder, Wouter W. https://orcid.org/0000-0003-1463-5165
- License Information
-
More Information
Article History
Received: 13 July 2022
Accepted: 6 October 2022
First Online: 11 November 2022
Compliance with ethical standards
:
: C.L.B.: Speaker’s bureau from Novartis; principal investigator for Novartis and Crinetics clinical trials; M.K.: Speaker’s bureau from Ipsen, NovoNordisk, Pfizer; grant support from Crinetics and ONO; A.A.: Employee of Costello Medical; A.M.G.: Member of the Spanish Association of Acromegaly; A.H.: Employee of Ipsen; holds stock options in Ipsen; A.R.O.J.: Employee of Ipsen; holds stock options in Ipsen; W.W.d.H.: Speaker’s bureau from Ipsen and Novartis; research support from Novartis; advisory board member for Camurus and Crinetics.
